Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 56

1.

Influenza vaccine--outmaneuvering antigenic shift and drift.

Treanor J.

N Engl J Med. 2004 Jan 15;350(3):218-20. No abstract available.

2.

Are we ready for pandemic influenza?

Webby RJ, Webster RG.

Science. 2003 Nov 28;302(5650):1519-22. Review.

PMID:
14645836
3.

Curtailing transmission of severe acute respiratory syndrome within a community and its hospital.

Lloyd-Smith JO, Galvani AP, Getz WM.

Proc Biol Sci. 2003 Oct 7;270(1528):1979-89.

4.

Severe acute respiratory syndrome-associated coronavirus genotype and its characterization.

Li L, Wang Z, Lu Y, Bao Q, Chen S, Wu N, Cheng S, Weng J, Zhang Y, Yan J, Mei L, Wang X, Zhu H, Yu Y, Zhang M, Li M, Yao J, Lu Q, Yao P, Bo X, Wo J, Wang S, Hu S.

Chin Med J (Engl). 2003 Sep;116(9):1288-92.

PMID:
14527350
5.

Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan.

Hsueh PR, Hsiao CH, Yeh SH, Wang WK, Chen PJ, Wang JT, Chang SC, Kao CL, Yang PC; SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital.

Emerg Infect Dis. 2003 Sep;9(9):1163-7.

6.

Role of China in the quest to define and control severe acute respiratory syndrome.

Breiman RF, Evans MR, Preiser W, Maguire J, Schnur A, Li A, Bekedam H, MacKenzie JS.

Emerg Infect Dis. 2003 Sep;9(9):1037-41. Review.

7.
8.

[Application of SIR model in forecasting and analyzing for SARS].

Chen Q.

Beijing Da Xue Xue Bao. 2003 May 31;35 Suppl:75-80. Chinese.

PMID:
12914225
9.

[Empirical analysis and forecasting for SARS epidemic situation].

Wang D, Zhao X.

Beijing Da Xue Xue Bao. 2003 May 31;35 Suppl:72-4. Chinese.

PMID:
12914224
10.

[Predict SARS infection with the small world network model].

Lin G, Jia X, Ouyang Q.

Beijing Da Xue Xue Bao. 2003 May 31;35 Suppl:66-9. Chinese.

PMID:
12914222
11.

SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism.

Chowell G, Fenimore PW, Castillo-Garsow MA, Castillo-Chavez C.

J Theor Biol. 2003 Sep 7;224(1):1-8.

PMID:
12900200
12.

Developing a highly contagious disease readiness plan: the SARS experience.

Augustine JJ.

Emerg Med Serv. 2003 Jul;32(7):77-83.

PMID:
12889429
13.

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).

Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC.

Thorax. 2003 Aug;58(8):686-9.

14.

Update: severe acute respiratory syndrome--worldwide and United States, 2003.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2003 Jul 18;52(28):664-5.

15.

SARS in China. China's missed chance.

Enserink M.

Science. 2003 Jul 18;301(5631):294-6. No abstract available.

PMID:
12869735
16.

SARS and population health technology.

Eysenbach G.

J Med Internet Res. 2003 Apr-Jun;5(2):e14.

17.

SARS: what have we learned?

Pearson H, Clarke T, Abbott A, Knight J, Cyranoski D.

Nature. 2003 Jul 10;424(6945):121-6. No abstract available.

PMID:
12853923
18.

[Death risk factors of severe acute respiratory syndrome with acute respiratory distress syndrome].

He WQ, Chen SB, Liu XQ, Li YM, Xiao ZL, Zhong NS.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Jun;15(6):336-7. Chinese.

PMID:
12837163
19.

Pandemic influenza and the global vaccine supply.

Fedson DS.

Clin Infect Dis. 2003 Jun 15;36(12):1552-61. Epub 2003 Jun 5.

PMID:
12802755
20.

Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection.

Ruan YJ, Wei CL, Ee AL, Vega VB, Thoreau H, Su ST, Chia JM, Ng P, Chiu KP, Lim L, Zhang T, Peng CK, Lin EO, Lee NM, Yee SL, Ng LF, Chee RE, Stanton LW, Long PM, Liu ET.

Lancet. 2003 May 24;361(9371):1779-85. Erratum in: Lancet. 2003 May 24;361(9371):1832.

PMID:
12781537

Supplemental Content

Support Center